Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
CHEO Genetics Diagnostic Laboratory, |
RCV001799345 | SCV002043495 | uncertain significance | Cardiomyopathy | 2019-09-17 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001868907 | SCV002201133 | likely benign | Lethal congenital glycogen storage disease of heart | 2022-06-27 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004734277 | SCV005360344 | uncertain significance | PRKAG2-related disorder | 2024-08-31 | no assertion criteria provided | clinical testing | The PRKAG2 c.820G>A variant is predicted to result in the amino acid substitution p.Val274Ile. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0065% of alleles in individuals of South Asian descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |